We developed a novel skin regeneration therapy combining nevus tissue inactivated by high 15 hydrostatic pressure (HHP) in the reconstruction of the dermis with a cultured epidermal 16 autograft (CEA). The issue with this treatment is the unstable survival of CEA on the 17 inactivated dermis. In this study, we applied collagen/gelatin sponge (CGS), which can sustain 18 the release of basic fibroblast growth factor (bFGF), to the inactivated skin in order to 19 accelerate angiogenesis. Murine skin grafts from C57BL6J/Jcl mice (8 mm in diameter) were 20 prepared, inactivated by HHP and cryopreserved. One month later, the grafts were transplanted 21 subcutaneously onto the back of other mice and covered by CGS impregnated with saline or 22 bFGF. Grafts were taken after one, two and eight weeks, at which point the survival was 23 evaluated through the histology and angiogenesis-related gene expressions were determined by 24 real-time polymerase chain reaction. Histological sections showed that the dermal cellular 25 density and newly formed capillaries in the bFGF group were significantly higher than in the 26 control group. The relative expression of FGF-2, PDGF-A and VEGF-A genes in the bFGF 27 group was significantly higher than in the control group at Week 1. This study suggested that 28 the angiogenesis into grafts was accelerated, which might improve the survival in combination 29 with the sustained release of bFGF by CGSs.
140 tissue were removed. The grafts were instantly frozen in liquid nitrogen to prevent RNA 141 degradation. Each frozen tissue sample was pulverized to a fine powder with a standard liquid 142 nitrogen pre-chilled mortar and pestle. This powder was then transferred to an RNase-free 1.5-143 ml tube (Eppendorf ® DNA LoBind tubes; Eppendorf Co., Hamburg, Germany) and 144 homogenized with 350 μl lysate solution, after which the total RNA was purified by column 145 precipitation using a NucleoSpin ® RNA Plus (Macherey-Nagel GmbH & Co. KG, Düren, 146 Germany) according to the manufacturer's instructions. The extracted total RNA was 147 quantitated by measuring the absorbance in a nanodrop spectrophotometer (Nanodrop ND-148 1000; Thermo Fisher Scientific, Wilmington, De, USA). The absorbance ratio at A260/A280 149 nm of all samples ranged from 1.8 to 2.1, indicating that they were pure during the RNA 150 extraction procedures. The quality and purity of the extracted RNA were also determined by 151 electrophoresis on a 1.5% (w/v) agarose gel containing ethidium bromide (EtBr) and visualized 152 under UV light (FAS-IV; Nippon Genetics Co., Ltd., Tokyo, Japan).
153
RT-PCR was performed to detect the expression of growth factors related to angiogenesis, 154 including FGF-2, PDGF-A and vascular endothelial growth factor-A (VEGF-A). 189 and anti-CD31 immunohistochemistry was used to evaluate newly formed capillaries in the 190 grafts at Weeks 1 and 2. For staining, 5-μm-thick sections were deparaffinized and rehydrated, 191 and then antigen retrieval processing was performed using the heat-induced target retrieval 192 method. Sections were immersed in a pre-heated staining dish containing EDTA buffer (pH 9;
